Moderna, Inc.
MRNA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001682852
In the last 90 days, Moderna, Inc. insiders filed 0 open-market purchases and 5 sales; 784 institutions reported holding it in 13F filings for Q2 2026, worth $22.3B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Moderna, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 5 filings
- 4 insiders, $49.2M in total
- Insiders trading
- 4
- Net value
- −$49.2M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Moderna, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Hoge Stephen | President | 1,562,029 | Sep 16, 2026 | 13 |
| Mock James M | Chief Financial Officer | 59,375 | Sep 14, 2026 | 16 |
| Klinger Shannon Thyme | Chief Legal Officer | 81,340 | Sep 8, 2026 | 12 |
| Bancel Stephane | Chief Executive Officer | 6,440,260 | Aug 7, 2026 | 4 |
| McDonnell Michael R | Director | – | Jul 10, 2026 | 1 |
| Banque Soria Ester | Chief Commercial Officer | – | Jul 7, 2026 | 1 |
| Afeyan Noubar | Director | 3,924Indirect | May 22, 2026 | 3 |
| Tallett Elizabeth E | Director | 4,761 | May 8, 2026 | 2 |
| Nader Francois | Director | 32,781 | May 8, 2026 | 2 |
| Rubenstein David M. | Director | 9,643 | May 8, 2026 | 2 |
| Nabel Elizabeth G | Director | 19,317 | May 8, 2026 | 2 |
| Horning Sandra | Director | 18,585 | May 8, 2026 | 2 |
| Hussain Abbas | Director | 12,066 | May 8, 2026 | 4 |
| Sagan Paul | Director | 312,027Indirect | May 1, 2025 | 0 |
| Langer Robert | Director | 11,467,664 | May 7, 2024 | 0 |
| Berenson Stephen | Director | 22,203 | May 7, 2024 | 0 |
| Garay Arpa | Chief Commercial Officer | 3,690 | Dec 7, 2023 | 0 |
| Andres Juan | See remarks | 12,803 | Dec 30, 2022 | 0 |
| Burton Paul | Chief Medical Officer | 954 | Nov 8, 2022 | 0 |
| Meline David W | Chief Financial Officer | 2,857 | Aug 11, 2022 | 0 |
| Zaks Tal Zvi | Chief Medical Officer | 0 | Jul 2, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 12, 2025 (view filing) | Jun 11 | 1 day | Hussain AbbasDirector | SSale | −312 | $28.00 | −$8.74K | −35.0%580 after | 10b5-1 |
| Dec 11, 2025 (view filing) | Dec 9 | 2 days | Hussain AbbasDirector | SSale | −504 | $27.60 | −$13.9K | −25.0%1.51K after | 10b5-1 |
| Dec 15, 2025 (view filing) | Dec 11 | 4 days | Afeyan NoubarDirector | SSale | −23.9K | $29.49 | −$703.4K | −85.9%3.92K after | |
| Feb 25, 2026 (view filing) | Feb 23 | 2 days | Hoge StephenPresident | SSale | −160.0K | $48.84 | −$7.81M | −9.9%1.46M after | 10b5-1 |
| Mar 3, 2026 (view filing) | Mar 2 | 1 day | Klinger Shannon ThymeChief Legal Officer | SSale | −13.9K | $52.29 | −$726.0K | −18.9%59.7K after | 10b5-1 |
| May 4, 2026 (view filing) | May 1 | 3 days | Hussain AbbasDirector | SSale | −5.68K | $46.63 | −$265.0K | −32.0%12.1K after | 10b5-1 |
| May 18, 2026 (view filing) | May 15 | 3 days | Hoge StephenPresident | SSale | −53.3K | $48.40 | −$2.58M | −3.5%1.48M after | 10b5-1 |
| May 22, 2026 (view filing) | May 21 | 1 day | Afeyan NoubarDirector | SSale | −9.26K | $46.84 | −$433.9K | −70.2%3.92K after | |
| Jun 8, 2026 (view filing) | Jun 4 | 4 days | Klinger Shannon ThymeChief Legal Officer | SSale | −3.47K | $50.00 | −$173.6K | −4.9%67.5K after | 10b5-1 |
| Jun 17, 2026 (view filing) | Jun 15 | 2 days | Hoge StephenPresident | SSale | −53.3K | $51.37 | −$2.74M | −3.5%1.48M after | 10b5-1 |
| Jul 16, 2026 (view filing)4:45 PM ET | Jul 15 | 1 day | Hoge StephenPresident | SSale | −53.3K | $67.60 | −$3.61M | −3.5%1.48M after | 10b5-1 |
| Aug 7, 2026 (view filing)4:11 PM ET | Aug 5 | 2 days | Bancel StephaneChief Executive Officer | SSale | −499.2K | $57.52 | −$28.7M | −7.5%6.19M after | 4 lots10b5-1 |
| Sep 3, 2026 (view filing)4:56 PM ET | Sep 1 | 2 days | Klinger Shannon ThymeChief Legal Officer | SSale | −3.47K | $139.95 | −$485.8K | −4.5%74.1K after | 10b5-1 |
| Sep 14, 2026 (view filing)4:25 PM ET | Sep 10 | 4 days | Mock James MChief Financial Officer | SSale | −34.8K | $134.49 | −$4.69M | −37.0%59.4K after | 2 lots10b5-1 |
| Sep 16, 2026 (view filing)4:48 PM ET | Sep 14-15 | 2 days | Hoge StephenPresident | SSale | −80.6K | $145.10 | −$11.7M | −4.9%1.56M after | 2 lots10b5-1 |